392 related articles for article (PubMed ID: 26195653)
1. Use and effects of cannabinoids in military veterans with posttraumatic stress disorder.
Betthauser K; Pilz J; Vollmer LE
Am J Health Syst Pharm; 2015 Aug; 72(15):1279-84. PubMed ID: 26195653
[TBL] [Abstract][Full Text] [Related]
2. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review.
Orsolini L; Chiappini S; Volpe U; Berardis D; Latini R; Papanti GD; Corkery AJM
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31450833
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention.
Mizrachi Zer-Aviv T; Segev A; Akirav I
Behav Pharmacol; 2016 Oct; 27(7):561-9. PubMed ID: 27551883
[TBL] [Abstract][Full Text] [Related]
4. Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review.
Steenkamp MM; Blessing EM; Galatzer-Levy IR; Hollahan LC; Anderson WT
Depress Anxiety; 2017 Mar; 34(3):207-216. PubMed ID: 28245077
[TBL] [Abstract][Full Text] [Related]
5. Correlates of Nonimprovement to Pharmacotherapy for Chronic, Antidepressant-Resistant, Military Service-Related Posttraumatic Stress Disorder: Insights From the Veterans Affairs Cooperative Study No. 504.
Byrne SP; Krystal JH; Rosenheck RA; Vessicchio J; Pietrzak RH;
J Clin Psychopharmacol; 2017 Dec; 37(6):717-721. PubMed ID: 28945664
[TBL] [Abstract][Full Text] [Related]
6. Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans.
Wolfgang AS; Hoge CW
JAMA Psychiatry; 2023 Sep; 80(9):869-870. PubMed ID: 37436761
[TBL] [Abstract][Full Text] [Related]
7. Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.
Hill MN; Campolongo P; Yehuda R; Patel S
Neuropsychopharmacology; 2018 Jan; 43(1):80-102. PubMed ID: 28745306
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans.
Chadwick VL; Rohleder C; Koethe D; Leweke FM
Curr Opin Psychiatry; 2020 Jan; 33(1):20-42. PubMed ID: 31714262
[TBL] [Abstract][Full Text] [Related]
9. Use of cannabinoids for the treatment of patients with post-traumatic stress disorder.
Forsythe ML; Boileau AJ
J Basic Clin Physiol Pharmacol; 2021 Mar; 33(2):121-132. PubMed ID: 33662194
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoids as an Emerging Therapy for Posttraumatic Stress Disorder and Substance Use Disorders.
Cohen J; Wei Z; Phang J; Laprairie RB; Zhang Y
J Clin Neurophysiol; 2020 Jan; 37(1):28-34. PubMed ID: 31895187
[TBL] [Abstract][Full Text] [Related]
11. Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review.
Stanciu CN; Brunette MF; Teja N; Budney AJ
Psychiatr Serv; 2021 Apr; 72(4):429-436. PubMed ID: 33530732
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review of the Clinical Effects of Cannabis and Cannabinoids in Posttraumatic Stress Disorder Symptoms and Symptom Clusters.
Rodas JD; George TP; Hassan AN
J Clin Psychiatry; 2024 Feb; 85(1):. PubMed ID: 38353645
[No Abstract] [Full Text] [Related]
13. Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence.
Passie T; Emrich HM; Karst M; Brandt SD; Halpern JH
Drug Test Anal; 2012; 4(7-8):649-59. PubMed ID: 22736575
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for posttraumatic stress disorder.
Stein DJ; Zungu-Dirwayi N; van Der Linden GJ ; Seedat S
Cochrane Database Syst Rev; 2000; (4):CD002795. PubMed ID: 11034765
[TBL] [Abstract][Full Text] [Related]
15. The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review.
Hindocha C; Cousijn J; Rall M; Bloomfield MAP
J Dual Diagn; 2020; 16(1):120-139. PubMed ID: 31479625
[No Abstract] [Full Text] [Related]
16. The efficacy of prazosin for the treatment of posttraumatic stress disorder nightmares in U.S. military veterans.
Breen A; Blankley K; Fine J
J Am Assoc Nurse Pract; 2017 Feb; 29(2):65-69. PubMed ID: 27977074
[TBL] [Abstract][Full Text] [Related]
17. Elucidating the transdiagnostic dimensional structure of trauma-related psychopathology: Findings from VA cooperative study 504 - risperidone treatment for military service related chronic post traumatic stress disorder.
Pietrzak RH; Rosenheck RA; Cramer JA; Vessichio JC; Tsai J; Southwick SM; Krystal JH;
J Affect Disord; 2015 Feb; 172():331-6. PubMed ID: 25451434
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid interventions for PTSD: Where to next?
Ney LJ; Matthews A; Bruno R; Felmingham KL
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():124-140. PubMed ID: 30946942
[TBL] [Abstract][Full Text] [Related]
19. Dynamic interplay between PTSD symptoms and posttraumatic growth in older military veterans.
Whealin JM; Pitts B; Tsai J; Rivera C; Fogle BM; Southwick SM; Pietrzak RH
J Affect Disord; 2020 May; 269():185-191. PubMed ID: 32339132
[TBL] [Abstract][Full Text] [Related]
20. Cannabis use among U.S. military veterans with subthreshold or threshold posttraumatic stress disorder: Psychiatric comorbidities, functioning, and strategies for coping with posttraumatic stress symptoms.
Hill ML; Loflin M; Nichter B; Na PJ; Herzog S; Norman SB; Pietrzak RH
J Trauma Stress; 2022 Aug; 35(4):1154-1166. PubMed ID: 35275431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
